GGrantIndex
← Search

ACTG A5163: A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF ON

$9,899M01FY2006RRNIH

University Of Minnesota, Minneapolis MN

Investigators

Linked publications & trials

View original record on NIH RePORTER →
ACTG A5163: A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF ON · GrantIndex